A B S T R AC T Objective: To assess the estrogenic activity of hydroalcoholic extract of Clitoria (C.) ternatea leaves in female Wistar rats. Methods: Hydroalcoholic extract of C. ternatea leaves prepared by using cold maceration method was tested for estrogenic activity. An acute toxicity study was conducted to estimate the safe dose using OECD 423 guidelines. For estrogenic activity, ovariectomized female rats were divided into four groups, with 6 rats in each group. The control and standard groups were administered with 1% carboxymethyl cellulose orally and estradiol valerate at 1 μg/rat/day subcutaneously, respectively. The third group was administered with hydroalcoholic extract of C. ternatea at the dose 500 mg/kg body weight orally and the fourth group was administered with hydroalcoholic extract of C. ternatea at the dose 500 mg/kg body weight orally along with estradiol valerate at dose 1 μg/rat/day subcutaneously. All treatments lasted for 7 consecutive days and estrogenic activity was assessed by observing vaginal cornfication. On day 8, all animals were sacrificed and uterine horns were dissected out. Utrine weight was measured and blood serum was further processed for the estimation of biochemical parameters like cholesterol, total proteins, alkaline phosphatase and estrogen by autoanylser. Histological studies of uterus were also carried out. Results: Acute toxicity studies indicated the hydroalcoholic extract of C. ternatea leave was found to be safe up to the dose level of 2 000 mg/kg. Oral administration of C. ternatea extract at the dose 500 mg/kg body weight and and estradiol valerate (1 μg/rat/ day) caused morphological changes i.e. increase in uterine weight, vaginal opening and cornification of cells; biochemical changes i.e. increase in cholesterol, total protein, alkaline phosphatase and estrogen contents; histological changes i.e. increase in uterine diameter, thickness and height of endometrium. Simultaneous administration of C. ternatea extract with estradiol valerate showed a synergistic effect. Histological investigations further confirmed the strong estrogenic nature of C. ternatea extract. Conclusions: C. ternatea extract (500 mg/kg) showed a significant estrogenic activity which is also supported by biochemical and histological studies. So, on the basis of these findings, it can be concluded that C. ternatea can be used as an alternative to synthetic oral contraceptives.
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. Introduction
The population boom has produced a grave hindrance in the commercial development, resources availability and all-around human progress in emerging nations [1] . According to the latest world population prospects, India population subsumed 17.74% of the total world population [2] . Current pandemic population growth demands an immediate improvement of new potential contraceptives [3] . Investigations and reports of numerous years have emphasized the unmet demand for reliable, affordable, and acceptable contraceptives to evade unwanted pregnancies.
The search for the oral herbal contraceptives is as old as recorded history [4] . Although various synthetic contraceptives are available in the market, they are in limited use due to their adverse side effects. Thus, there is a demand for herbal medicines, which have the least side effects [5] .
India has an enormous wealth of medicinal plants due to climate diversity, and Clitoria (C.) ternatea Linn. (Fabaceae) is one of the plants originated from the humid and lowland tropics with alluring and charming flowers available in two varieties; blue & white [6] . It is commonly known as "Aparajita". It has many pharmacological activities like antioxidant, anticancer, anti-diabetic, insecticidal, anti-inflammatory, anti-microbial and many other pharmacological activities [7] . In the traditional (Asian) Indian systems of medicine and Ayurveda pharmacopeia, the roots, seeds, and leaves of C. ternatea has also been used as a brain stimulant and is believed to promote memory and intelligence [8] . The lead phytoconstituents reported are tannins, flavonoids, flavonol glycosides, anthraquinone, cardiac glycosides, volatile oils, saponins, and steroids. Specifically, the leaves are the rich source of phenolic compounds like 3-monoglucoside, 3-rutinoside, neohisperidoside, aparajitin, beta-sitosterol, kaempferol 3-O-rhamnosyl, and essential oils [9] .
Phytochemicals from traditional medicinal plants, like steroids [10] , flavonoids (flavones, flavanones, and isoflavones) [11] , alkaloids [12] and phenolic compounds [13] have already been reported in the literature for their antifertility activity. Plants such as Michelia champaca [14] , Jatropha gossypifolia [15] , Aloe barbadensis [16] , Derri [17] , Tragia involucrata [18] , Amaranthus spinous [19] , Drosera burmanni [20] , Achyranthus aspera [21] , Cassia occidentalis [22] , etc. have been used as oral contraceptives since ages. So, the present study was undertaken to established the ethnomedicinal antifiertilty claim of plant by assessing estrogenic activity of hydroalcoholic extract of C. ternatea Linn. leaves on rats.
Materials and methods

Animals
Thirty-three female Wistar rats (100-120 g; 45-60 days old) were retrieved from the animal house, Lala Lajpat Rai University of Veterinary and Animal Sciences (Reg. No 1669/GO/abc/12/ CPCSEA), Hisar, Haryana, India. The animals were kept in an institutional animal house for 7 days for acclimation. Female rats were bestowed in polypropylene cages with rice husk as bedding material and maintained at (27±2) 曟 , relative humidity (65±10)% under a 12-hour light/dark cycle. The animals were bolstered with rat pellet diet and water ad libitum. 
Procurement and identification of plant material
Preparation of extract
The leaves of C. ternatea were cleaned in running tap water to remove adhering impurities and dried under shade. Then the leaves were pulverized into coarse powder by a mechanical grinder, passed through sieve No. 40 and stored in an impermeable container at room temperature. The extraction of 600 g powdered leaves of C. ternatea was carried out by cold maceration method with hydro-alcohol (10 : 90). The extract was concentrated to semi-solid mass by using rotary evaporator under reduced pressure and then lyophilized. The crude yield of the lyophilized extract was 11.8% w/w. The extract was stored at 4 曟 in a refrigerator for further evaluation.
Phytochemical screening
Phytoconstituents were identified in the hydroalcoholic extract of C. ternatea leaves by using the established chemical methodology to establish its identity and purity [23, 24] .
Acute toxicity study
The acute toxicity study of hydroalcoholic extract of C. ternatea was determined in 9 female Wistar rats, under standard conditions. Toxicity study was executed as per the OECD Guidelines 423. Overnight fasting of animals was done before the experimentation. The test substance at a single dose (2 000 mg/kg) for the limit test was administered by oral gavage. The limit test was performed by the previous pilot experimentation, which indicated that the extracts were likely to be non-toxic up to the regulatory limit dose [19] .
Animal grouping
Twenty-four mature female rats of Wistar strain (100-120 g; 45-60 days old) were used for the estrogenic activity. They were bilaterally ovariectomized under light anesthesia. The uterine horns were exteriorized by laparotomy incision and ovaries were excised. After one week, the ovariectomized rats were divided into 4 groups, with 6 rats in each group. Group 1 (the control group) was administered with 1% carboxymethyl cellulose p.o.; Group 2 (the standard group) received standard drug i.e. estradiol valerate in arachis oil injected subcutaneously (1 μg/rat/day); Group 3 received 500 mg/kg body weight (b.w.) hydroalcoholic extract of C. ternatea in carboxymethyl cellulose suspension p.o.; Group 4 simultaneously received both hydroalcoholic extract of C. ternatea (500 mg/kg/b.w.) p.o. and estradiol valerate (1 μg/rat/day) subcutaneously. All treatments lasted for 7 consecutive days.
Estrogenic activity
Estrogenic activity was assessed by observing vaginal opening and cornification. At the assigned time period, i.e. the 8th day, all animals were sacrificed under light anesthesia; uterine horns were quickly dissected out; liberated from adhering fat, blotted, weighed quickly on a sensitive balance and uterine weight was measured. The uterine tissues were preserved in 10% formalin solution, dehydrated in alcohol and embedded in paraffin.
Biochemical parameters
Blood (1 mL) was collected by the retro-orbital puncture method before sacrificing the animals. Blood was centrifuged for 10 min at 10 000 rpm, and the serum was separated from the blood for the estimation of biochemical parameters like estrogen level, alkaline phosphates, total proteins, and cholesterolby Merck kit autoanalyser [25] .
Histological findings
For histological studies, paraffin blocks were sectioned and stained with a hematoxylin-eosin solution (H & E stain). The stained slides were examined microscopically (400×) to determine the diameter of the uterus, the thickness of the endometrium, and the height of endometrial epithelium in 10 randomly selected sections by using a calibrated ocular micrometer.
Statistical analysis
All data were expressed as mean±standard deviation (mean±SD). Means were statistically analyzed by one-way analysis of variance followed by Dunnett's test using Graphpad InStat software version 7.05 [26] . P<0.05 was considered significant.
Ethical approval
Animal ethical clearance was accessed from Institutional Animal Ethical Committee (Protocol No. IPS/IAEC/2017/294), performing the experimental work for contraceptive activity.
Results
Phytochemical analysis
Preliminary phytochemical analysis of the hydroalcoholic extract revealed the presence of saponins, steroids, alkaloids, flavonol glycosides, flavonoids, carbohydrates, volatile oils, and tannins which releaved the presence of same phytoconstituents as reported in the literature.
Acute toxicity study
The dose was considered to be safe up to 2 000 mg/kg, orally. At 2 000 mg/kg, no morbidity and mortality were detected in the animals. Hence, 1/5th of this dose, i.e. (500 mg/kg) was used for the antifertility activity.
Estrogenic activity
Oral administration of hydroalcoholic extract of C. ternatea at 500 mg/kg b.w. caused a significant increase in the uterine weight versus the control group (P<0.01). The uterotropic changes, like the diameter of the uterus (P<0.01), height and thickness of endometrium (P<0.01) were significantly increased when compared with the control rats (Table 1 and 2) .
The uteri of group 3 animals were inflated and full of fluid resembling the proestrous/estrous uterus. These animals also showed vaginal opening. Examination of vaginal smears of treated rats revealed predominantly cornified and nucleated epithelial cells. However, their number was less than that in estradiol valerate treated rats. Simultaneous administration of estradiol valerate and hydroalcoholic extract of C. ternatea caused a significant increase in the uterine weight, uterine diameter (versus the control; P<0.01), cornification and keratinization of cells in the vaginal smear. Synergistic effect with estradiol valerate further corroborated its estrogenic activity. It appeared that the hydroalcoholic extract had estrogenic activity at the dose of 500 mg/kg.
Biochemical parameters
The present findings also supported that hydroalcoholic extract of C. ternatea behaved like an estrogenic substance as it increased the protein and chloestrol content in the serum (P<0.05) (Table 3) . Further, its combined administration with estradiol valerate acted in a synergistic way and these findings corroborated that protein and cholesterol content was estrogen motivated. The hydroalcoholic extract of C. ternatea (500 mg/kg, p.o.) when administered alone or conjointly with estradiol valerate to mature ovariectomized rats significantly (P<0.01) increased the estrogen level, in comparison to the control, indicating the estrogenic nature of the extract (Table 3 ).
An increment in alkaline phosphatase was found after estrogen administration. After the oral administration of hydroalcoholic extract of C. ternatea (500 mg/kg), the activity of soluble phosphate increased (P<0.01) as shown in Table 3 . Conjoint treatment of C. ternatea extract and estradiol valerate acted synergistically. These findings also provided strength to the estrogenic nature of the extract.
Histology findings
The hydroalcoholic extract of C. ternatea significantly increased the weight of uteri (Table 1) , and results obtained were also correlated and supported by the histology findings as shown in Table 2 and Figure 1 .
The hydroalcoholic extract of C. ternatea at the dose 500 mg/kg showed a significant increase in the number of uterine glands, enhanced glandular secretion, enlarged uterine lumen, and an increase in the height of luminal epithelium when compared to the control group, therefore showing the estrogenic nature ( Figure 1C) . Animals in the control group showed confined lumen, compact stroma, atrophic endometrium, inactive endometrial glands, basal nuclei, and less cytoplasm ( Figure 1A) . The uterus of estradiol valerate-treated animals showed obliterated lumen lined with stratified columnar epithelium, stimulated uterine glands with loose and edematous stroma, the thickness of endometrium and height of luminal epithelium were increased ( Figure 1B) . A synergistic effect was manifested by the group where hydroalcoholic extract of C. ternatea (500 mg/kg) conjointly administered with the standard drug, i.e. estradiol valerate reported dilated endometrial glands constituted by large cuboidal cells, distinct centralized and pronounced nucleoli ( Figure 1D ). The plant products having estrogenic nature were known to increase and that of antiestrogenic property tended to decrease the cholesterol, total proteins, alkaline phosphatase and estradiol level in ovariectomized rats. In general, protein content was directly proportional to the uterine weight. So, increment in protein content of reproductive system was responsible for the increase in uterine weight. Previous reports on antifertility activity also highlight the similar estrogenic effect on uterine histology after oral administration of various plant extracts [15, 28, 29] . Different phytoconstituents occurring in a variety of plants like steroids [10] , 毬 -sitosterol [30] , flavonoids (flavones, flavanones, and isoflavones) [11] , alkaloids [12] and phenolic compounds have well been known to possess antifertility activity [13] . ternatea might be due to the presence of such compounds.
Discussion
In conclusion, based on the above perceptions i.e. morphological, biochemical and histological studies, it might be presumed that hydroalcoholic extract of C. ternatea leaves inferable from its intense estrogenic nature alters the biochemical and hormonal milieu in the conceptive tract, which further changes the natural phenomenon of the reproduction in the females. Hence, the antifertility activity of the hydroalcoholic extract of C. ternatea may be due to its inherent estrogenic activity and these research findings provide the basis for the antifertility activity of C. ternatea as claimed in the customary use. Further studies are going on in our laboratory to find out the active constituents and the exact mechanism of action involved in fertility regulation of this plant.
